[Subchondral bone tissues in osteoarthritis of knee joint: a tetracycline labelling study].
The patients with late osteoarthritis of the knee joint were given oral tetracycline to label the newly formed bone tissues before they were subjected to high tibial osteotomies or knee replacements. During the operation, the sclerotic subchondral bone tissue of the tibia and/or femur were procured. The bone specimens were processed into undecalcified sections and studied under fluorescence microscope. Apart from the autofluorescence of the trabeculae, strips of golden green labelled fluorescence of high intensity were noted along their peripheries, indicating that there were formatting and deposition of new bone along the periphery of the trabeculae. These new bone tissues were produced by the osteoblasts abutting the trabecular periphery. In the fatty tissues of the marrow interstices between the trabeculae, scattered dots and small flakes of golden green labelled fluorescence emerged at first. Then the labelled-fluorescent dots and flakes agglomerated into large pieces of more intense fluorescence with concomitant decrease in fatty tissues. Eventually, these large pieces of labelled fluorescence fused with those of the trabeculae and there was a further decrease in fatty tissues. These findings suggested that the formation and deposition of new bone tissues in the marrow interstices proceeded according to above three stages. The new bone tissues were produced by marrow stromal cells. The two kinds of new bone tissues increased the bone mass and rendered sclerotic changes in upper end of the tibia and lower end of the femur in osteoarthritis of knee joint.
Chai
B F
BF
Shanghai Institute of Traumatology and Orthopaedics.
D002358:Cartilage, Articular / Q000473:pathology*; D006801:Humans; D007719:Knee Joint / Q000473:pathology*; D008856:Microscopy, Fluorescence; D010003:Osteoarthritis / Q000150:complications / Q000473:pathology*; D010026:Osteosclerosis / Q000209:etiology; D013752:Tetracycline
D013752:Tetracycline